Ultraweak Photon Emission Imaging for Oxidative Stress Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical imaging technologies lack effective methods for early detection and monitoring of pathological conditions, particularly those associated with oxidative stress, and fail to provide timely interventions or guide treatment efficiently.

Innovation Solution

The use of ultraweak photon emission (UPE) imaging, enhanced by low-level light illumination (LLLI), to measure oxidative stress and analyze imaging data for detection, diagnosis, prognosis, and monitoring of pathological conditions, supporting medical treatment and assessing treatment efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional medical imaging technologies are used, then imaging can be performed, but early detection and monitoring of pathological conditions associated with oxidative stress cannot be achieved

Engineering Contradiction:
Improvedetection capabilityVSAvoideffectiveness for early detection
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent introduces an intermediary substance (contrast agent or photosensitizer) that accumulates in distressed tissues and enhances UPE signal. This intermediary enables the imaging system to detect pathological conditions that would otherwise be invisible or indistinguishable from healthy tissue using conventional imaging methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the detection parameter from conventional anatomical imaging to ultraweak photon emission measurement. By detecting the faint light emitted by oxidative processes in distressed tissues, the system achieves early detection capability that conventional imaging technologies lack.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If UPE imaging is performed without enhancement, then imaging can be conducted, but signal contrast between healthy and distressed tissues is insufficient

Engineering Contradiction:
Improvesignal contrastVSAvoidimaging system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by illuminating the target area with low-level light before UPE imaging to stimulate oxidative processes and enhance the UPE signal from distressed tissues. This pre-treatment increases the contrast between healthy and distressed areas, making pathological conditions more detectable.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses an intermediary substance (contrast agent or photosensitizer) that selectively accumulates in distressed tissues and enhances UPE emission when exposed to light. This intermediary amplifies the signal from pathological areas without requiring complex device modifications.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If low level light illumination is applied to enhance UPE signal, then early detection capability is improved, but treatment time and energy consumption increase

Engineering Contradiction:
Improveearly detection capabilityVSAvoidtreatment time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies partial action by using low-level light illumination for a limited duration (1-60 minutes) rather than continuous treatment. This partial application is sufficient to stimulate oxidative processes and enhance UPE signal without requiring excessive treatment time or energy consumption.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables early detection of pathological conditions, guiding timely interventions and assessing treatment efficacy by enhancing UPE signal contrast between healthy and distressed tissues, facilitating personalized treatment plans.

Implementation Method 1

enhancing formation of the reactive oxygen species and/or the reactive nitrogen species comprises applying low level light illumination to the target area from 1 second to 60 minutes

Methodology Applied
Scientific EffectPhotobiomodulation: Photo-oxidation

Implementation Method 2

acquiring an ultraweak photon emission image of a target area of a patient for detection of a pathological condition

Methodology Applied
Scientific EffectUltraweak photon emission detection: Luminescence

Data Source

PatentUS11504006B2Non-invasive imaging systems and methods of use
Publication Date: 2022.11.22 ORI IMAGING INC
  • US11504006B2 patent drawing
  • US11504006B2 patent drawing
  • US11504006B2 patent drawing

AI summary

Some embodiments of the present disclosure are directed to ultraweak photon emission imaging systems and methods. In some embodiments, a method comprises acquiring an ultraweak photon emission image of a target area of a patient for detection of a pathological condition; wherein the target area comprises an area of interest and a portion surrounding the area of interest, wherein acquiring the image comprises: enhancing formation of reactive oxygen species and/or reactive nitrogen species in the target area, wherein enhancing formation of the reactive oxygen species and/or the reactive nitrogen species comprises applying low level light illumination to the target area from 1 second to 60 minutes so as to achieve a total power output from 1 mW to 10,000 W using an average power density from 0.1 W/cm2 to 1 W/cm2; and imaging the target area, wherein imaging the target area comprises a total exposure time from 1 second to 60 minutes.